- Bloomberg and CNN among stations to run 30-second spot on Pyratine XR(TM) and Rosacea -
NAPA, Calif., June 26 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced today that on June 27, 2009 at 7:19 AM Eastern Time, a 30-second segment on Pyratine XR(TM) (0.125% furfuryl tetrahydropyranyl adenine) and rosacea, a condition afflicting more than 14 million Americans, will be broadcast on DIRECTV's NewsCluster. The NewsCluster includes Bloomberg, CNBC, CNN, FOX News, Headline News, MSNBC, Fox Business News, and The Weather Channel.
DIRECTV is America's #1 satellite television service with more than 18 million household viewers. The segment features a prominent board-certified dermatologist who discusses a rosacea specific study conducted at the Department of Dermatology,
Pyratine XR(TM) is marketed through select physicians in North America by Senetek PLC and it was officially launched at the American Academy of Dermatology's 67th Annual Meeting in San Francisco, March 6-10, 2009.
About Senetek, PLC
Senetek PLC (OTCBB: SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sol
|SOURCE Senetek PLC|
Copyright©2009 PR Newswire.
All rights reserved